Akeso, Inc.

SHSC:9926 Stock Report

Market Cap: HK$54.6b

Akeso Past Earnings Performance

Past criteria checks 0/6

Akeso has been growing earnings at an average annual rate of 40.4%, while the Biotechs industry saw earnings growing at 31.7% annually. Revenues have been growing at an average rate of 80.1% per year.

Key information

40.4%

Earnings growth rate

53.4%

EPS growth rate

Biotechs Industry Growth11.0%
Revenue growth rate80.1%
Return on equity-15.5%
Net Margin-39.2%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Akeso makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

SHSC:9926 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 241,874-7351,1641,274
31 Mar 243,2006461,1271,264
31 Dec 234,5262,0281,0901,254
30 Sep 234,4392,0081,0711,278
30 Jun 234,3511,9871,0521,302
31 Mar 232,5954099021,313
31 Dec 22838-1,1687521,323
30 Sep 22549-1,2246721,239
30 Jun 22260-1,2805921,155
31 Mar 22243-1,1785081,139
31 Dec 21226-1,0754231,123
30 Sep 21177-1,0023241,107
30 Jun 21129-9292261,091
31 Mar 2164-983240930
31 Dec 200-1,036253769
30 Sep 2035-870197597
30 Jun 2071-703141426
31 Mar 2071-49298367
31 Dec 1971-28255308
31 Dec 183-14220161

Quality Earnings: 9926 is currently unprofitable.

Growing Profit Margin: 9926 is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 9926 is unprofitable, but has reduced losses over the past 5 years at a rate of 40.4% per year.

Accelerating Growth: Unable to compare 9926's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 9926 is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (7.1%).

Return on Equity

High ROE: 9926 has a negative Return on Equity (-15.49%), as it is currently unprofitable.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 23:20
End of Day Share Price 2024/12/20 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Akeso, Inc. is covered by 38 analysts. 19 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yonglin YanBOCI Research Ltd.
Sharon ShiBOCI Research Ltd.
Jiangqiao TongBOCI Research Ltd.